Semaglutide use in patients with type 2 diabetes (T2D) slightly increases the risk of nonarteritic anterior ischemic optic neuropathy (NAION), research published in JAMA Ophthalmology shows. The study ...

Bravo Mining Corp. (TSXV: BRVO) (OTCQX: BRVMF), ("Bravo" or the "Company") is pleased to announce that the Pará State Environmental Agency (Secretaria de Estado de Meio Ambiente e Sustentabilidade – ...

Non-arteritic anterior ischemic optic neuropathy (NAION) - also known as a "eye stroke" - typically causes sudden vision loss in one eye. It occurs from a lack of sufficient blood flow to the ...

Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. Cindy X. Cai, M.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues conducted a ...

TFPM.TO Triple Flag Precious Metals Corp.

Opens in a new tab or window Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes. The risk was more modest than ...

Semaglutide was tied to nonarteritic anterior ischemic optic neuropathy (NAION) risk vs. nonuse in adults with type 2 diabetes. New semaglutide users did not have higher NAION risk vs. most other ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.